Mitsuhiro Kometani
Overview
Explore the profile of Mitsuhiro Kometani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sawamura T, Karashima S, Ohmori A, Kometani M, Yoneda T
Geriatr Gerontol Int
. 2025 Feb;
PMID: 40001315
Tirzepatide could control postprandial hyperglycemia even in cases with diminished β-cell function. This finding gives new insight into the treatment of older patients with diabetes. However, tilzepatide does not replace...
2.
Noda Y, Kometani M, Nomura A, Noda M, Oka R, Kadono M, et al.
PLOS Digit Health
. 2024 Dec;
3(12):e0000648.
PMID: 39642163
Lifestyle-related diseases, such as diabetes, are mostly caused by poor lifestyle habits; therefore, modifying these habits is important. In Japan, a system of specific health checkups (SHC) and specific health...
3.
Aono D, Kato T, Morisawa A, Kimata S, Konishi S, Kometani M, et al.
Endocr J
. 2024 Dec;
72(3):325-332.
PMID: 39617463
Recently, the usefulness of circulating tumor DNA (ctDNA) analysis in various malignancies has been reported. However, reports on ctDNA analysis in adrenocortical carcinoma (ACC) are few. Therefore, this study aimed...
4.
Sawamura T, Mizoguchi R, Ohmori A, Kometani M, Yoneda T, Karashima S
J Diabetes Metab Disord
. 2024 Nov;
23(2):2105-2113.
PMID: 39610482
Objectives: Tirzepatide belongs to a new class of anti-diabetic agents that stimulate both glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors, resulting in a greater blood glucose-lowering effect and body weight...
5.
Goto H, Yamamoto Y, Tsujiguchi H, Sato T, Yamamoto R, Takeshita Y, et al.
J Endocr Soc
. 2024 Nov;
9(1):bvae198.
PMID: 39606181
Context: Oxytocin supplementation improves obstructive sleep apnea (OSA), and animal studies suggest involvement of oxytocin in respiratory control. However, the relationship between endogenous oxytocin signaling and human sleep status remains...
6.
Mai X, Kometani M, Kato T, Aiga K, Karashima S, Aono D, et al.
Endocr J
. 2024 Nov;
72(2):193-203.
PMID: 39603607
Pheochromocytoma is a rare form of adrenal hypertension. This study aimed to investigate the clinical characteristics and associated genetic mutations in patients with pheochromocytoma and primary aldosteronism. We retrospectively analyzed...
7.
Takeda Y, Demura M, Yoneda T, Karashima S, Kometani M, Aono D, et al.
Int J Mol Sci
. 2024 Nov;
25(22).
PMID: 39596027
The gene is sporadically expressed in the zona glomerulosa (ZG), whereas the gene is detected in the zona fasciculata (ZF)/reticularis (ZR), with predominant expression in the ZF. We studied the...
8.
Oiwa Y, Aiga K, Kometani M, Asano T, Usukura M, Yoneda T
JCEM Case Rep
. 2024 Nov;
2(12):luae213.
PMID: 39569045
Primary aldosteronism (PA) is the most common form of secondary hypertension. Recently, the genetic analysis of aldosterone-producing adenoma, a major cause of PA, has revealed several causative genes. Herein, we...
9.
Hirooka K, Higashide T, Sakaguchi K, Udagawa S, Sugiyama K, Oki K, et al.
Am J Ophthalmol
. 2024 Sep;
269:339-345.
PMID: 39284484
Purpose: To investigate patients with primary aldosteronism (PA) and the prevalence of normal-tension glaucoma (NTG). Design: Cross-sectional study. Methods: Newly diagnosed PA patients were evaluated in this cross-sectional study, with...
10.
Aiga K, Kometani M, Demura M, Yoneda T
JCEM Case Rep
. 2024 Jul;
2(7):luae119.
PMID: 39027636
Primary aldosteronism (PA) is a subtype of secondary hypertension categorized as either unilateral PA (eg, aldosterone-producing adenoma [APA]) or bilateral PA. CYP11B2, an aldosterone synthase, is highly expressed in APA....